Skip to content

Biodesix, Inc. BDSX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$31.96M+9.4%-$35.27M+10.8%-$39.54M+3.8%-$41.08M-1.6%-$40.42M+5.9%
$5.63M-0.8%$5.67M-1.1%$5.73M-1.5%$5.82M+0.4%$5.79M+0.3%
$4.28M+3.5%$4.14M-4.4%$4.33M-9.6%$4.79M-3.6%$4.97M-25.1%
-$25.62M-6.5%-$24.05M+14.6%-$28.15M+6.0%-$29.94M+28.6%-$41.94M+13.8%
$266K+2.7%$259K-74.4%$1.01M-15.3%$1.2M-61.1%$3.07M-5.0%
-$410K-1.7%-$403K+65.9%-$1.18M+15.6%-$1.4M+57.6%-$3.3M+4.0%
$19K-9.5%$21K-27.6%$29K-23.7%$38K-15.6%$45K-11.8%
$33.22M+102%$16.42M+11.6%$14.71M+46.6%$10.03M-80.5%$51.54M-1.3%
$6.11M+15,772%
-$25.8M-6.5%-$24.22M+16.9%-$29.16M+6.3%-$31.13M+30.8%-$45.01M+13.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Biodesix, Inc. generate?
Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
What is Biodesix, Inc.'s free cash flow?
After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
Where does Biodesix, Inc.'s cash flow data come from?
Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.